294 related articles for article (PubMed ID: 30179845)
1. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
2. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
3. Potential ameliorative effects of grape seed-derived polyphenols against cadmium induced prostatic deficits.
Lei Y; Chen Q; Chen J; Liu D
Biomed Pharmacother; 2017 Jul; 91():707-713. PubMed ID: 28499242
[TBL] [Abstract][Full Text] [Related]
4. Potential Ameliorative Effects of Qing Ye Dan Against Cadmium Induced Prostatic Deficits via Regulating Nrf-2/HO-1 and TGF-β1/Smad Pathways.
Du L; Lei Y; Chen J; Song H; Wu X
Cell Physiol Biochem; 2017; 43(4):1359-1368. PubMed ID: 28992620
[TBL] [Abstract][Full Text] [Related]
5. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
6. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
8. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
Kim HJ; Jin BR; An HJ
Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells.
Wang Y; Liu N; Su X; Zhou G; Sun G; Du F; Bian X; Wang B
Biomed Pharmacother; 2015 Mar; 70():260-7. PubMed ID: 25776510
[TBL] [Abstract][Full Text] [Related]
10. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia.
Tong S; Mo M; Hu X; Wu L; Chen M; Zhao C
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23391. PubMed ID: 37518988
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis.
Chen J; Du L; Li J; Song H
Food Chem Toxicol; 2016 Oct; 96():70-8. PubMed ID: 27474435
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1
Abdel-Naim AB; Neamatallah T; Eid BG; Esmat A; Alamoudi AJ; Abd El-Aziz GS; Ashour OM
Oxid Med Cell Longev; 2018; 2018():4389484. PubMed ID: 30154949
[TBL] [Abstract][Full Text] [Related]
13. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
14. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.
Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G
World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701
[TBL] [Abstract][Full Text] [Related]
15. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.
Funahashi Y; Wang Z; O'Malley KJ; Tyagi P; DeFranco DB; Gingrich JR; Takahashi R; Majima T; Gotoh M; Yoshimura N
Prostate; 2015 Mar; 75(4):381-9. PubMed ID: 25451715
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
17. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
18. GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition.
Kim Y; Lee D; Jo H; Go C; Yang J; Kang D; Kang JS
Aging (Albany NY); 2021 Feb; 13(3):3202-3217. PubMed ID: 33539321
[TBL] [Abstract][Full Text] [Related]
19. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
20. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats.
Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
